Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000128340 | SCV000171933 | benign | not specified | 2011-07-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000359434 | SCV000478293 | likely benign | Leigh syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000359434 | SCV000627063 | benign | Leigh syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000128340 | SCV000918301 | benign | not specified | 2017-12-18 | criteria provided, single submitter | clinical testing | Variant summary: The SURF1 c.280T>C (p.Leu94Leu) variant involves the alteration of a conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing and ESE sites at the locus are not predicted to be affected. However, these predictions have yet to be confirmed by functional studies. This variant was found in 10613/277080 control chromosomes (258 homozygotes) at a frequency of 0.038303, which is approximately 22 times the estimated maximal expected allele frequency of a pathogenic SURF1 variant (0.0017678), strongly suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories classified this variant as likely benign or benign. Taken together, this variant is classified as benign. |
Mayo Clinic Laboratories, |
RCV000676734 | SCV000802535 | benign | not provided | 2016-02-25 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000128340 | SCV001919550 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000128340 | SCV001957263 | benign | not specified | no assertion criteria provided | clinical testing |